Liver Diseases Therapeutics Market will grow at 9.7% CAGR, to be valued at US$ 24,921.3 Mn by 2028: Impact of COVID-19
Liver Diseases Therapeutics are used for treatment of hepatitis A, hepatitis B, and hepatitis C; liver fibrosis, liver cancer and Wilson disease. SEATTLE, WASHINGTON, UNITED STATES, February 7, 2022 /EINPresswire.com/ -- Liver Diseases Therapeutics …